Related Experiment Video
Updated: Aug 15, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
M C Marin1, C A Jost, L A Brooks
1Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
The p73 protein, a homologue of the tumour-suppressor protein p53, can activate p53-responsive promoters and induce apoptosis in p53-deficient cells. Here we report that some tumour-derived p53 mutants can bind to and inactivate p73. The binding of such mutants is influenced by whether TP53 (encoding p53) codon 72, by virtue of a common polymorphism in the human population, encodes Arg or Pro. The ability of mutant p53 to bind p73, neutralize p73-induced apoptosis and transform cells in cooperation with EJ-Ras was enhanced when codon 72 encoded Arg. We found that the Arg-containing allele was preferentially mutated and retained in squamous cell tumours arising in Arg/Pro germline heterozygotes. Thus, inactivation of p53 family members may contribute to the biological properties of a subset of p53 mutants, and a polymorphic residue within p53 affects mutant behaviour.
Insights
Tumor-derived p53 mutants can inactivate the related p73 protein. A common genetic variation in TP53 (p53 gene) influences this interaction, affecting cancer development in some patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p73 protein, a homolog of the tumor suppressor p53, can activate p53-responsive promoters and induce apoptosis in p53-deficient cells.
- Tumor-derived p53 mutants are frequently found in various cancers, and their mechanisms of action are crucial for understanding tumorigenesis.
Purpose of the Study:
- To investigate the interaction between tumor-derived p53 mutants and the p73 protein.
- To determine the role of the common TP53 codon 72 polymorphism (Arg vs. Pro) in this interaction and its functional consequences.
Main Methods:
- Co-immunoprecipitation assays to assess binding between p53 mutants and p73.
- Apoptosis assays to evaluate the functional impact of p53-p73 interaction on cell death.
- Cell transformation assays in cooperation with EJ-Ras.
- Analysis of TP53 mutation and allele retention in patient tumor samples.
Main Results:
- Certain tumor-derived p53 mutants bind to and inactivate p73.
- The binding affinity and inactivating capacity of p53 mutants towards p73 are influenced by the codon 72 polymorphism, with Arg-encoding alleles showing enhanced effects.
- Mutant p53's ability to neutralize p73-induced apoptosis and cooperate with EJ-Ras for cell transformation is enhanced when codon 72 encodes Arg.
- The Arg-containing allele was preferentially mutated and retained in squamous cell tumors from individuals heterozygous for the Arg/Pro polymorphism.
Conclusions:
- Inactivation of p53 family members by mutant p53 contributes to the biological properties of a subset of p53 mutants.
- A polymorphic residue within p53 significantly affects the behavior of p53 mutants, influencing their interaction with p73 and potentially impacting cancer progression.
Related Concept Videos
Mutations
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epistasis Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

